Sitemap - 2024 - Geneva Health Files

[EXCLUSIVE] Lobbying Disclosures in the US: How Big Pharma Fought the TRIPS Waiver & is Pushing for Strong Intellectual Property Protection in the Pandemic Agreement

Renewed Push for A December Deadline To Conclude The Pandemic Agreement

Financing: Don't Let It Be An Afterthought In The Pandemic Agreement [Guest Essay]

Missive from Berlin: World Health Summit 2024

Mandatory & Universal Nutrition Labelling: Pressures and Interests

Review of the TRIPS Agreement at the WTO: Reforming TRIPS for Global Equity

Mapping Digitization of Health Services in India: Strengths, Vulnerabilities & Opportunities

Geneva Health Files July-September 2024 [The GHF WRAP]

"Everyone should benefit from science. That's a progressive understanding of science": Colin Carlson on the Pathogen Access & Benefits Sharing System

Pathogen Data Access Not Assured Without Agreed Benefits: Emerging Position from Some Developing Countries [Update: Pandemic Agreement Talks]

Slow Progress as Schism Continues Between Countries [Update: Pandemic Agreement Talks]

Mpox - A Critical Reminder For Obligations To Prioritize & Invest in Universal Health Coverage in the Pandemic Agreement [GUEST ESSAY]

Countries Sink Teeth into the Form of a Pandemic Agreement [INB11 Update]

"Scientists Have Control & Can Decide Where to Share Data": Colin J Carlson on The Pathogen Access & Benefits Sharing Mechanism [THE FILES INTERVIEW]

Lessons From The Negotiations On The Pandemic Agreement: Key Learnings Over Two Years [GHF Dialogues]

Mpox Response Reveals Governance Shifts in Global Health, Presents Evidence on Policy Constraints

UN Tax Convention: A Structural Transformation for Financing Health [Guest Essay]

Watch: The Story of Geneva Health Files

To Fight Mpox, Release Vaccine Stockpiles [Guest Essay]

Resource & Access Challenges Constrain Mpox Response As WHO Elevates It To Public Health Emergency of International Concern (PHEIC)

Watchdog Investigations Show Attempts by Philip Morris Japan to Target The Young & Influence Policymakers To Sell Heated Tobacco Product

IHR 2005 Amendments: Setting the Legal Framework for Equity [Guest Essay]

The Wrong Remedy: What Proposed Pull Incentives for Antimicrobial Research & Development Ignore About Antimicrobial Resistance (AMR) [Guest Essay]

Tense Discussions On Process & Way Forward: Pandemic Agreement Talks Set For An Uphill Climb to Consensus

Developing Countries Push for a Review of TRIPS Agreement at the WTO, Stalled by Few Developed Countries

The Geneva Health Files Impact Report

The Evolution of Global Health: Tracing Historical Ideas and Practices [Essay]

Geneva Health Files April-June 2024 [The GHF WRAP]

Cataclysmic: The Proposed Dismantling of the MSF Access Campaign Strikes At the Heart of Influential Activism, Political-Legal Battles in Global Health At Stake

"The Art of the Possible": Unpacking the Negotiations on the Amendments to the International Health Regulations [The Files Interview]

Consensus on the Historic Amendments to the International Health Regulations: How It Happened.

Announcing the Geneva Health Files Advisory & Editorial Boards

Gaza's Healthcare Collapse: A Global Failure to Uphold International Humanitarian Law

Podcasting As a Way to Break Barriers in Global Health: A Conversation with Garry Aslanyan

Countries Agree on Vital Disclosure Requirements on Genetic Resources & Traditional Knowledge at WIPO: A Win for Greater Balance in IP Politics [Guest Essay]

Announcing the Geneva Health Files Summer Fellows 2024

Countries Voted Eight Times in a Politicized World Health Assembly Revealing Geopolitical Fissures [WHA77]

WHO Member States Score a Win on IHR and for Multilateralism, Bag More Time to Conclude Pandemic Agreement [WHA77]

Crunch Time: Countries Determined to Adopt Amendments to the IHR, Divided on the Way Ahead to Conclude Pandemic Agreement [WHA77]

WHO Launches Investment Round Amidst Burden of Expectations [WHA77]; Push For IHR, Time for Treaty

Chaotic Process & Politics Affect Pandemic Agreement Negotiations at WHO As Countries Struggle to Reach Consensus, Could Risk IHR Process

Attempts to Discredit Communication from South African Presidency on Pandemic Agreement Negotiations, Creates Confusion At a Key Juncture

African Markers: Letter from the South African Presidency on the Negotiations for a Pandemic Agreement

The WIPO Diplomatic Conference on Intellectual Property, Genetic Resources, and Traditional Knowledge, Gets off to a Start in Geneva [GUEST ESSAY]

Close, But Not Yet: Consensus Pending on the Amendments to the International Health Regulations

WHO gears up for “Investment Round” amidst tough climate for financing. Up to $4 billion in the pipeline to meet $7.1 billion funding gap over four years

Pandemic Agreement Talks On Borrowed Time, Fate of Amendments to International Health Regulations At Stake

Consensus Elusive. Countries to Decide Next Steps, Likely to Request Additional Time To Conclude Pandemic Agreement

Rupture in Africa Group Muddies Waters, But Developing Countries are Fighting Back for Equity Considerations in Pathogen Access & Benefit Sharing

The Contested Space of Intellectual Property Rules in a Pandemic Agreement: Terms of Technology Transfer & the Unease with the Peace Clause [INB9]

[GUEST ESSAY] One Health: A Bargaining Chip in the Pandemic Agreement Negotiations?

A Turning Point? The EU & the U.S. Draw Out Four African Countries to Bridge Positions on Pathogen Access & Benefit Sharing

The Depth of The Divide: Reluctance to Link Pathogen Access to Benefit-Sharing. An Approaching Tipping Point in the Negotiations as Countries Stick to Their Positions

Pandemic Agreement Talks: The Final Toss - Access & Benefits Sharing Vs One Health? Health Financing Politics Come into Play as Africa Group Holds the Wild Card

IHR Goes into Extra Time: Countries Make Definite Progress on the Amendments to the International Health Regulations, But Not Enough to Close a Deal [WG-IHR8]

“Equity and Financing are Really Key to Probably Doing the Deal Ultimately”: WG-IHR Co-Chairs Asiri & Bloomfield on the Amendments to IHR

“Equity” Stands A Chance In the International Health Regulations. Without Financing, Compliance At Stake [WG-IHR8]

Pressure Builds On Countries To Embrace Weak Pandemic Agreement, Operationalizing Equity at Risk with a Framework Approach

EXCLUSIVE: Next Draft of The Pandemic Agreement Will Likely Have No Fund and No Binding Obligations On Pathogen Access & Benefits Sharing, Defers Modalities to Conference of Parties

[GUEST ESSAY] Principles to Guide the Pathogen Access-and-Benefit Sharing System [PABS] in a Pandemic Agreement; Update: Proposal to Buy More Time to Operationalize PABS by May 2026

What Readers Are Telling Us

How The EU Prepares For the Next Global Pandemic Domestically: An Examination of the Union Compulsory Licence [Guest Essay]

Developing Countries Call for a Review of the TRIPS Agreement at the WTO

A Robust PABS System: Make or Break for the Pandemic Accord [Guest Essay]

Geneva Health Files is Four; Jan-April 2024 [GHF WRAP]

The Fate of the Pandemic Agreement Hangs in Balance, Will be Determined by “Process”. Hinges on a Deal on Access & Benefits-Sharing Mechanism [INB9 WRAP]

Pressure To Conclude Pandemic Agreement Mounts, But Countries Hold Onto Positions [Update INB9]

Shift in Position: Pharma Industry is Warming Up to "Pathogen Access & Benefits Sharing", But Wants Unconditional Access Sans Obligations on Sharing Benefits

Negotiating Text for Pandemic Agreement Gets Panned by Developed Countries, Stage Set For Tough Fight

Pandemic Agreement Negotiations: Countries Rearing To Go, But Concerns on Process Continue [INB9 PRIMER]

New Negotiating Text of the Pandemic Agreement: Watered Down Language, But Ticks Boxes on Key Provisions

"Equity" in the International Health Regulations, Makes it to the Negotiating Table

Reforms to the International Health Regulations Must Advance Human Rights [GUEST ESSAY]; TRIPS Extension Decision for COVID-19 Tests & Treatments Junked at WTO Ministerial

Mild Optimism? Countries Keen on Reaching May 2024 Finish Line for WHO’s New Pandemic Instrument, Within A Handful of Negotiating Days [INB8 WRAP]

The Challenges in Aligning Two Track Negotiations in Global Health: Equity, Financing, Governance & Monitoring as Sticking Points

On the Brink of Legitimizing Inequity: Negotiations at WHO for a Pandemic Instrument & Amending the IHR [Guest Essay]

Pandemic Regulations or Pandemic Agreement? Growing Affinity for Article 21 Over Article 19 of WHO Constitution, as Some “Treaty” Proponents Rethink Underlying Legal Provisions of New Rules [INB8]

Developing Countries Mean Business on Equity Provisions in Pandemic Agreement. Will it Count?

Will Countries Begin Text-Based Negotiations for a Pandemic Agreement Next Week: The What, How and Why Not? [PRIMER INB8]

WTO Members Agree to Disagree on TRIPS Extension Decision; Misfired: When the WTO Got Lovesick

Call: Geneva Health Files Fellowship 2024

Equity Provisions in the IHR: A Race Against Time

Developing Countries Seek to Retain Equity Provisions in the Amendments to the IHR [WGIHR7 Update]

WHO’s Global Health & Peace Initiative: Political or Diplomatic? [EB154]

Geneva Health Files Launches New Website!

WTO to Pull the Plug on Extension Decision on COVID-19 Tests & Treatments. TRIPS Chair Calls for “Conclusion” as Talks "Exhausted"

Regressive Politics on Climate & Gender, Crash Against WHO’s Gates, Impinging on Global Health Policy Space [EB154]

Green Light for WHO to Raise Resources to Beef Up Finances; Countries Set Tighter Processes To Streamline WHO Spending [EB154]

Headwinds from Climate Politics at WHO Executive Board Meeting [EB154]

Proposed New Technical Committee to Streamline Functioning of WHO Governing Bodies [EB154 PRIMER]

Embedded: Examining Management Consultants in Global Health [GUEST ESSAY]

WHO Seeks to Raise US$7 Billion in First Ever Investment Round in 2024, Executive Board to Consider Proposal This Month